Page 112 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

CHAPTER 5
Supplementary table 1. Baseline traditional cardiovascular risk factors and the association with disease activity
DAS28 levels B (CI)
ESR levels B (CI)
CRP levels B (CI)
Age, years
BMI, kg/m2
Systolic BP, mmHg†
p
< 0.001
0.001
3.328
(1.834-4.821) (0.071-0.273)
p
< 0.001
< 0.001
p
< 0.001
0.236
0.002
0.008
0.012
0.592
< 0.001
< 0.001
0.875
p
0.526
0.020
2.250 (1.412-3.089)
0.556 (0.231-0.880)
0.152 (0.103-0.202)
0.035 (0.016-0.054)
0.093 (0.042-0.145)
0.013 (-0.008-0.034)
< 0.001
0.172
0.001 0.167 (0.061-0.272)
0.004 0.084 (0.022-0.146)
0.077 -0.006 (-0.010- -0.001)
0.537 -0.001 (-0.005-0.003)
1.760 < 0.001 0.087
Diastolic BP,
mmHg† (0.893-2.627) (0.028-0.145)
TChol, mmol/l‡
LDL, mmol/l‡
HDL, mmol/l‡
TChol:HDL ratio‡
-0.068 0.076 -0.004 (-0.412-0.007) (-0.009-0.000)
-0.026 0.450 -0.001 (-0.093-0.041) (-0.005-0.003)
-0.067 (-0.097- -0.038)
0.161
(0.066-0.257) (0.003-0.014)
< 0.001
-0.004 (-0.006--0.002)
< 0.001
0.004
0.310
p
0.179
0.259
-0.005 (-0.007--0.003)
0.011 (0.005-0.017)
0.000 (-0.002-0.003)
OR (CI)
1.003 (0.994-1.017)
0.990 (0.982-0.998)
0.001
0.009
0.041 0.067 0.001
Triglycerides,
mmol/l‡ (-0.003-0.084) (-0.001-0.004)
OR (CI) p OR (CI)
Current smoking 1.101 0.178 0.994 (yes/no) (0.957-1.267) (0.985-1.003)
Gender (male/ 1.183 0.025 1.005 female) (1.021-1.370) (0.996-1.014)
† In patients who did not use antihypertensive drugs, n = 360. ‡ In
statins, n = 417. ABI: ankle brachial index; B: beta; BMI: body mass
pressure; CI: confidence interval; CRP: C-reactive protein; DAS28:
Score; ESR: erythrocyte sedimentation rate; HDL: high-density lipoprotein; HR: heart rate; LDL: low-density lipoprotein; OR: odds ratio; TChol: total cholesterol
110
patients who did not use index; BP: diastolic blood 28-joint Disease Activity